Statements & Press Releases

Sep 18, 2023

PUTT Official Statement to the FTC on Updated Merger Guidelines

Re: Support for the Federal Trade Commission's Draft Updated Guidelines for Mergers

Jul 20, 2023

PUTT Statement to the FTC on PBM Advocacy

On behalf of our nation’s independent pharmacies and their patients, we urge the FTC to vote in favor of issuing a statement cautioning pharmacy benefit managers (PBMs) against relying on previous FTC advocacy materials opposing PBM transparency as part of their public relations / image management campaign.

Jul 5, 2023

PUTT: WISCONSIN APPELLATE COURT RULING AFFIRMS OPTUMRX CONTRACTS ARE “UNCONSCIONABLE”, CALLS ON ILLINOIS SUPREME COURT TO OVERTURN EARLIER ILLINOIS APPELLATE COURT RULING

Illinois Court Ruling Would Ultimately Harm Patients and Their Pharmacies Under “Unreasonable and Unconstitutional” Terms of Forced Arbitration

May 26, 2023

Bravo to American Pharmacy Cooperative, Inc. for Calling On “Big 3” PBMs’ Largest Investor to Use Its Influence To Restrain PBM Economically Damaging Practices

This week American Pharmacy Cooperative, Inc. (APCI) took a bold step in the ongoing campaign for PBM reform: they openly called on Vanguard Inc., the largest investor of in the parent companies of the “Big 3” pharmacy benefit managers (PBMs), to use its influence to curtail their PBMs’ abuse of patients and pharmacies....

May 8, 2023

PUTT: ILLINOIS APPELLATE COURT WRONG TO REVERSE CALIFORNIA APPELLATE RULING CALLING FORCED ARBITRATION UNCONSCIONABLE

Illinois Court Ruling Ultimately Hurts All Small Businesses Attempting to Compete in a World Dominated by Mega-Corporations

Apr 21, 2023

FLORIDA CLOSER TO PASSING PRESCRIPTION DRUG REFORM LEGISLATION FOLLOWING STATE SENATE UNANIMOUS VOTE

Independent Pharmacy Organizations’ Collective Efforts are Helping Propel Governor DeSantis Goal of Requiring PBMs to Comply with Standards of Due Care, Skill and Professionalism

Mar 16, 2023

CALIFORNIA COURT OF APPEALS UPHOLDS LOWER COURT RULING CALLING OPTUMRX’S FORCED ARBITRATION CONTRACT CLAUSE “UNCONSCIONABLE”

Decision Affirms Lower Court Ruling, Opens the Door for Independent Pharmacies to Publicly Hold OptumRx Accountable for Wrongdoings

Mar 7, 2023

PUTT to Governor DeSantis: Thank You for Having the Guts to Take On Pharmacy Benefit Middlemen, Change Status Quo for Floridians

Governor DeSantis’ Bold Leadership is an Example to Other States Seeking to Stop PBMs from Profiteering Off Consumers, Employers and Taxpayers

Feb 23, 2023

PUTT Statement on Commissioner Christine Wilson’s FTC Departure

Jan 9, 2023

PUTT Comment to the FTC RE: Unfair or Deceptive Fees Trade Regulation Rule Commission Matter No. R207011

Jul 8, 2022

PUTT: GOVERNOR DESANTIS’ BOLD STAND FOR DRUG PRICE TRANSPARENCY PROVES STATES CAN AND SHOULD LEAD THE WAY ON PBM REFORM

Jun 17, 2022

PUTT APPLAUDS FTC VOTE TO LAUNCH PBM STUDY AND FTC FOR ISSUING ENFORCEMENT POLICY STATEMENT FOLLOWING INSULIN HEARING

Jun 8, 2022

FTC Launches 6(b) Study of PBMs, Votes to Order the 6 Largest PBMs to Turn Over Documents and Data as Part of Study

Apr 20, 2022

PUTT Sign-On Letter to the FTC Regarding PBM Practices and Their Harm to the Healthcare System

Apr 20, 2022

Millions Overpaid for Prescriptions in Secretive Scheme, Lawsuit Filed by Attorney General Jeff Landry to Recover Inflated Charges

Mar 7, 2022

PUTT Statement to CMS Regarding the Medicare DIR Fee Proposed Rule Change

RE: Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare
Advantage and Medicare Prescription Drug Benefit Programs (CMS-4192-P)

Feb 18, 2022

PUTT STATEMENT ON THE FAILURE OF THE FTC TO AUTHORIZE STUDY OF PBM-PHARMACY RELATIONSHIP FOLLOWING IMPASSIONED PUBLIC HEARING

Commissioners Wilson and Phillips: Your Actions Lead Us to Wonder if You Participated in the Hearing with an Open Mind, or if You are Protecting the Rights of Modern-Day Robber Barons

Dec 31, 2021